US Stock MarketDetailed Quotes
ANIP ANI Pharmaceuticals
- 55.500
- +1.340+2.47%
Close Dec 26 16:00 ET
- 55.500
- 0.0000.00%
Post 16:37 ET
1.17BMarket Cap-118.09P/E (TTM)
55.580High52.890Low248.02KVolume54.000Open54.160Pre Close13.59MTurnover1.55%Turnover Ratio65.29P/E (Static)21.02MShares70.81052wk High2.87P/B890.91MFloat Cap52.50052wk Low--Dividend TTM16.05MShs Float392.040Historical High--Div YieldTTM4.97%Amplitude4.800Historical Low54.798Avg Price1Lot Size
ANI Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -61.22%12.47M | -15.57%17.41M | -14.73%18.27M | 481.24%118.96M | 1,116.82%44.74M | 787.91%32.17M | 279.61%20.63M | 213.10%21.42M | -1,039.28%-31.2M | 63.89%-4.4M |
| Net income from continuing operations | -343.12%-24.17M | -136.62%-2.29M | 1,165.25%18.21M | 139.21%18.78M | 127.22%1.16M | 215.58%9.94M | 141.85%6.25M | 107.15%1.44M | -12.42%-47.9M | 82.42%-4.24M |
| Operating gains losses | --7.47M | --0 | ---5.35M | ---- | ---- | ---- | ---- | ---- | -106.04%-750K | --0 |
| Depreciation and amortization | 3.56%15.75M | 0.05%14.7M | -0.10%14.69M | 0.23%59.79M | -2.43%15.19M | -0.93%15.21M | 3.64%14.69M | 0.98%14.7M | 26.24%59.65M | 13.80%15.57M |
| Deferred tax | -71.57%-5.59M | -108.68%-1.9M | 301.55%3.1M | 23.03%-11.74M | -413.60%-8.35M | -44.76%-3.26M | 76.75%-910K | 110.36%773K | 8.96%-15.25M | 79.91%-1.63M |
| Other non cash items | 722.98%4.55M | -60.04%832K | -71.00%565K | -27.84%6.62M | 13.55%3.32M | -115.82%-731K | 2,027.78%2.08M | 12.28%1.95M | 204.45%9.17M | 125.81%2.92M |
| Change In working capital | 49.62%8.33M | 33.06%-4.51M | -476.38%-10.23M | 148.46%24.86M | 233.88%27.8M | 159.43%5.57M | 34.62%-6.73M | 83.69%-1.77M | -60,971.43%-51.3M | -24,817.86%-20.76M |
| -Change in receivables | 242.58%8.44M | 253.66%6.33M | -11.47%-10.34M | 109.10%3.36M | 167.04%16.76M | -159.32%-5.92M | 109.52%1.79M | -199.29%-9.28M | -565.32%-36.91M | -565.38%-25.01M |
| -Change in inventory | -180.42%-6.36M | -1,635.58%-11.61M | -255.26%-2.64M | 75.28%-5.84M | 51.33%-4.61M | 31.52%-2.27M | 92.88%-669K | 216.35%1.7M | -832.82%-23.63M | -70.52%-9.46M |
| -Change in prepaid assets | 816.89%13.08M | -3,163.69%-10.61M | -10.58%1.35M | -1,029.70%-9.02M | -145.36%-8.38M | -273.06%-1.82M | -119.12%-325K | 1,204.38%1.51M | -728.35%-798K | -163.91%-3.42M |
| -Change in payables and accrued expense | -149.53%-6.9M | 422.05%10.34M | -149.58%-1.77M | 222.31%40.08M | 45.65%25.78M | 186.18%13.94M | -119.07%-3.21M | 160.26%3.57M | 383.26%12.44M | 12,364.79%17.7M |
| -Change in other working capital | -95.30%77K | 124.22%1.05M | 345.16%3.17M | -55.15%-3.72M | -203.10%-1.76M | 279.23%1.64M | -558.63%-4.31M | 387.50%713K | -136.89%-2.4M | -141.15%-581K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -61.22%12.47M | -15.57%17.41M | -14.73%18.27M | 481.24%118.96M | 1,116.82%44.74M | 787.91%32.17M | 279.61%20.63M | 213.10%21.42M | -1,039.28%-31.2M | 63.89%-4.4M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -8,652.95%-398.52M | 34.82%-4.45M | 479.64%8.93M | -17.62%-18.51M | -52.10%-4.78M | 53.61%-4.55M | -1,030.13%-6.83M | -8.03%-2.35M | 85.08%-15.74M | 96.18%-3.14M |
| Net PPE purchase and sale | -176.71%-4.81M | -77.89%-4.45M | 480.29%8.93M | -9.13%-8.87M | 27.37%-2.28M | 29.54%-1.74M | -338.00%-2.5M | -20.52%-2.35M | -8,932.61%-8.13M | -236.85%-3.14M |
| Net intangibles purchase and sale | 77.58%-631K | --0 | --0 | -27.23%-9.64M | -62,400.00%-2.5M | 61.69%-2.81M | ---4.33M | 98.25%-4K | 64.05%-7.58M | 66.67%-4K |
| Net business purchase and sale | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- | 99.96%-33K | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -8,652.95%-398.52M | 34.82%-4.45M | 479.64%8.93M | -17.62%-18.51M | -52.10%-4.78M | 53.61%-4.55M | -1,030.13%-6.83M | -8.03%-2.35M | 85.08%-15.74M | 96.18%-3.14M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 7,650.47%291.03M | -101.81%-1.45M | -333.73%-19.73M | 1,415.63%67.44M | -2,246.06%-11.92M | 512.18%3.76M | 5,677.59%80.15M | -100.35%-4.55M | -102.63%-5.13M | -100.28%-508K |
| Net issuance payments of debt | 46,600.00%348.75M | 0.00%-750K | 0.00%-750K | 0.00%-3M | 0.00%-750K | 0.00%-750K | 0.00%-750K | 0.00%-750K | -103.03%-3M | -100.90%-750K |
| Net common stock issuance | --0 | -89.70%8.66M | -144.04%-8.66M | 3,957.48%75.57M | -4,090.76%-4.99M | --0 | 17,512.84%84.1M | -217.44%-3.55M | -102.85%-1.96M | -100.17%-119K |
| Net preferred stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| Cash dividends paid | 0.00%-406K | 0.00%-407K | 0.00%-406K | 0.00%-1.63M | 0.25%-406K | 0.00%-406K | 0.00%-407K | -0.25%-406K | -755.26%-1.63M | -114.21%-407K |
| Proceeds from stock option exercised by employees | -89.57%512K | -220.20%-8.96M | 1,550.32%2.59M | 517.01%9M | 775.65%6.73M | 914.67%4.91M | -1,477.83%-2.8M | 5,133.33%157K | -29.53%1.46M | -55.68%768K |
| Net other financing activities | ---57.83M | --0 | ---12.5M | ---12.5M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 7,650.47%291.03M | -101.81%-1.45M | -333.73%-19.73M | 1,415.63%67.44M | -2,246.06%-11.92M | 512.18%3.76M | 5,677.59%80.15M | -100.35%-4.55M | -102.63%-5.13M | -100.28%-508K |
| Net cash flow | ||||||||||
| Beginning cash position | 48.48%240.11M | 237.38%228.6M | 315.38%221.12M | -49.45%53.23M | 215.05%193.08M | 136.46%161.71M | -17.28%67.76M | -49.45%53.23M | 718.38%105.3M | 202.56%61.28M |
| Current changes in cash | -402.88%-95.02M | -87.75%11.51M | -48.52%7.48M | 422.44%167.89M | 448.36%28.04M | 541.72%31.37M | 794.64%93.95M | 162.09%14.52M | -156.33%-52.07M | -109.47%-8.05M |
| End cash Position | -24.89%145.02M | 48.48%240.11M | 237.38%228.6M | 315.38%221.12M | 315.38%221.12M | 215.05%193.08M | 136.46%161.71M | -17.28%67.76M | -49.45%53.23M | -49.45%53.23M |
| Free cash flow | -74.54%7.03M | -6.05%12.97M | -28.23%13.69M | 310.77%100.45M | 629.85%39.96M | 546.07%27.62M | 207.77%13.8M | 190.30%19.07M | -134.58%-47.66M | 39.92%-7.54M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data